A patient has been successfully resuscitated after experiencing a myocardial infarction (MI). Due to mild cardiac impairment and hypotension, which medication is most likely to be prescribed to stabilize the patient's condition

1. A

   Adrenaline

2. B

   Dopamine

3. C

   Dobutamine

4. D

   Noradrenaline

Appeared in: NORCET 3 - 2022 (Shift-2)

Explanation

Listen in Hindi

• Dobutamine is a selective beta-1 adrenergic agonist, making it a potent inotropic agent.
• Its primary mechanism is to increase myocardial contractility and stroke volume, which directly addresses the 'cardiac impairment' (pump failure) seen after an MI.
• By improving cardiac output, dobutamine helps restore tissue perfusion and can stabilize blood pressure, making it the drug of choice for cardiogenic shock when severe hypotension is not the dominant feature.
• Compared to other agents, it has a lower risk of causing excessive tachycardia or arrhythmias, which is a critical consideration in a post-MI patient.

Why Other Options Were Wrong

• Option A: Adrenaline is a non-selective adrenergic agonist that causes significant increases in heart rate, contractility, and vasoconstriction. This dramatically increases myocardial oxygen demand, which can worsen ischemia in a heart already damaged by an MI.
• Option B: Dopamine has dose-dependent effects and a higher propensity to cause tachycardia and arrhythmias compared to dobutamine. These side effects increase cardiac workload and are undesirable in a post-MI patient.
• Option D: Noradrenaline is primarily a potent vasopressor with less inotropic effect than dobutamine. While it effectively raises blood pressure, it does not primarily address the underlying problem of poor myocardial contractility in this scenario.

Related Visual

• Visual 1: Diagram: A chart comparing the effects of Adrenaline, Noradrenaline, Dopamine, and Dobutamine on alpha-1, beta-1, and beta-2 receptors to illustrate their different mechanisms of action.
• Visual 2: Flowchart: A decision-making algorithm for managing cardiogenic shock, showing when to choose an inotrope (like Dobutamine) versus a vasopressor (like Noradrenaline).

Clinical Relevance

• Nursing practice connection: Safe nursing care depends on performing Pharmacological management of cardiogenic shock following myocardial infarction in the correct sequence, documenting the action clearly, and monitoring for the expected response.
• Nurses administering inotropic or vasopressor infusions must perform continuous monitoring of vital signs, including heart rate, blood pressure (often via an arterial line), and ECG for arrhythmias.
• The IV site must be assessed frequently for signs of extravasation, as these drugs can cause severe tissue necrosis if they leak from the vein. A central line is the preferred route for administration.
• Accurate titration of the infusion rate according to the prescribed parameters and the patient's hemodynamic response is a critical nursing responsibility to ensure patient safety and therapeutic effectiveness.

How to Approach the Question

• First, identify the patient's core problems from the stem: 1) 'mild cardiac impairment' (a pump problem) and 2) 'hypotension' (a pressure problem).
• Recognize that the hypotension is likely a consequence of the cardiac impairment (cardiogenic shock). Therefore, the primary therapeutic goal is to improve the pump's function.
• Evaluate the options based on their primary mechanism of action. Look for the drug that most directly improves cardiac contractility (inotropy).
• Dobutamine is a selective beta-1 agonist, making it a powerful inotrope. This directly targets the 'cardiac impairment'.
• Consider the side effects. Rule out options that would be overly stressful for a post-MI heart, such as Adrenaline (high oxygen demand) and Dopamine (high arrhythmia risk).
• Differentiate between an inotrope (Dobutamine) and a vasopressor (Noradrenaline). Since the root cause is pump failure, starting with an inotrope is the most logical first step.

Concept Tested & Keywords

• Concept Tested: Pharmacological management of cardiogenic shock following myocardial infarction.
• Stem keywords: myocardial infarction (MI), cardiac impairment, hypotension, resuscitation
• Lead-in keywords: most likely
• Clinical cues: The combination of 'mild cardiac impairment' and 'hypotension' points to early cardiogenic shock where improving contractility is the priority.

Question ID

QSQyc42sof9uJ5CEERaUSB

Copy ID